The pharmacokinetics of commonly used antiepileptic drugs in immature CD1 mice

NeuroReport

Volumn 21, Issue 6, 2010, Pages 452-456

  Markowitz, Geoffrey J ^a   Kadam, Shilpa D ^a,b   Boothe, Dawn M ^c   Irving, Natasha D ^a   Comi, Anne M ^a,b  

^a KENNEDY KRIEGER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AUBURN UNIVERSITY   (United States)

Author keywords

Antiepileptic drugs; Brain to blood ratios; Immature mice; Pharmacokinetics; Plasma levels

Indexed keywords

ANTICONVULSIVE AGENT;

ANIMAL; ARTICLE; BLOOD; BRAIN; DISEASE MODEL; DRUG EFFECT; EPILEPSY; GROWTH, DEVELOPMENT AND AGING; HALF LIFE TIME; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; MOUSE; MOUSE STRAIN; SPECIES DIFFERENCE;

ANIMALS; ANTICONVULSANTS; BRAIN; DISEASE MODELS, ANIMAL; EPILEPSY; HALF-LIFE; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED STRAINS; SPECIES SPECIFICITY;

EID: 79955522873     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0b013e328338ba18     Document Type: Article

References (24)

1. Jensen FE. Pediatric epilepsy models. Epilepsy Res 2006; 68:28-31. (Pubitemid 43052774)
2. Jan MM, Camfield PR. Outcome of neonatal stroke in full-term infants without significant birth asphyxia. Eur J Pediatr 1998; 157:846-848. (Pubitemid 28460748)
3. Kadam SD, Mulholland JD, Smith DR, Johnston MV, Comi AM. Chronic brain injury and behavioral impairments in a mouse model of term neonatal strokes. Behav Brain Res 2009; 197:77-83.
4. Gilman JT, Duchowny M, Campo AE. Pharmacokinetic considerations in the treatment of childhood epilepsy. Paediatr Drugs 2003; 5:267-277. (Pubitemid 36469933)
5. Bittigau P, Sifringer M, Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Ann N Y Acad Sci 2003; 993:103-114. (Pubitemid 36808438)
6. Stefovska VG, Uckermann O, Czuczwar M, Smitka M, Czuczwar P, Kis J, et al. Sedative and anticonvulsant drugs suppress postnatal neurogenesis. Ann Neurol 2008; 64:434-445.
7. Benedetti MS, Coupez R, Whomsley R, Nicolas JM, Collart P, Baltes E. Comparative pharmacokinetics and metabolism of levetiracetam, a new anti-epileptic agent, in mouse, rat, rabbit and dog. Xenobiotica 2004; 34:281-300. (Pubitemid 38478896)
8. Greenblatt DJ, Sethy VH. Benzodiazepine concentrations in brain directly reflect receptor occupancy: studies of diazepam, lorazepam, and oxazepam. Psychopharmacology (Berl) 1990; 102:373-378. (Pubitemid 20335065)
9. Gerber N, Arnold K. Studies on the metabolism of diphenylhydantoin in mice. J Pharmacol Exp Ther 1969; 167:77-90.
10. Iven H, Feldbusch E. Pharmacokinetics of phenobarbital and propylhexedrine after administration of barbexaclone in the mouse. Naunyn Schmiedebergs Arch Pharmacol 1983; 324:153-159. (Pubitemid 13023550)
11. Loscher W, Esenwein H. Pharmacokinetics of sodium valproate in dog and mouse. Arzneimittelforschung 1978; 28:782-787. (Pubitemid 8326665)
12. Neels HM, Sierens AC, Naelaerts K, Scharpe SL, Hatfield GM, Lambert WE. Therapeutic drug monitoring of old and newer anti-epileptic drugs. Clin Chem Lab Med 2004; 42:1228-1255. (Pubitemid 39600327)
13. Loscher W. The pharmacokinetics of antiepileptic drugs in rats: consequences for maintaining effective drug levels during prolonged drug administration in rat models of epilepsy. Epilepsia 2007; 48:1245-1258. (Pubitemid 47063087)
14. Bialer M, Twyman RE, White HS. Correlation analysis between anticonvulsant ED50 values of antiepileptic drugs in mice and rats and their therapeutic doses and plasma levels. Epilepsy Behav 2004; 5:866-872. (Pubitemid 40003907)
15. Habgood MD, Knott GW, Dziegielewska KM, Saunders NR. The nature of the decrease in blood-cerebrospinal fluid barrier exchange during postnatal brain development in the rat. J Physiol 1993; 468:73-83. (Pubitemid 23254434)
16. Luna-Tortos C, Fedrowitz M, Loscher W. Several major antiepileptic drugs are substrates for human P-glycoprotein. Neuropharmacology 2008; 55:1364-1375.
17. Sills GJ, Kwan P, Butler E, de Lange EC, van den Berg DJ, Brodie MJ. P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice. Epilepsy Behav 2002; 3:427-432. (Pubitemid 35460411)
18. Nishimura A, Honda N, Sugioka N, Takada K, Shibata N. Evaluation of carbamazepine pharmacokinetic profiles in mice with kainic acid-induced acute seizures. Biol Pharm Bull 2008; 31:2302-2308.
19. Kniesel U, Risau W, Wolburg H. Development of blood-brain barrier tight junctions in the rat cortex. Brain Res Dev Brain Res 1996; 96:229-240. (Pubitemid 26348299)
20. Rascher G, Wolburg H. The tight junctions of the leptomeningeal blood-cerebrospinal fluid barrier during development. J Hirnforsch 1997; 38:525-540. (Pubitemid 127497708)
21. Saunders NR, Knott GW, Dziegielewska KM. Barriers in the immature brain. Cell Mol Neurobiol 2000; 20:29-40. (Pubitemid 30090914)
22. Daood M, Tsai C, Ahdab-Barmada M, Watchko JF. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Neuropediatrics 2008; 39:211-218.
23. Matsuoka Y, Okazaki M, Kitamura Y, Taniguchi T. Developmental expression of P-glycoprotein (multidrug resistance gene product) in the rat brain. J Neurobiol 1999; 39:383-392. (Pubitemid 29239201)
24. Brodie BB, Kurz H, Schanker LS. The importance of dissociaton constant and lipid-solubility in influencing the passage of drugs into the cerebrospinal fluid. J Pharmacol Exp Ther 1960; 130:20-25.